Learn more about the study and apply at To view or add a comment, sign in Kessler Foundation's John DeLuca, PhD, senior vice president of research and training, and co-director of the Foundation's Center for Multiple Sclerosis Research, gave a keynote address at the 2025 Comprehensive Academic Annual Conference of the Chinese Association of Rehabilitation Medicine & International Exhibition on Rehabilitation Medicine Industry in Beijing, China
Understanding Purging vs
Although initial findings suggest that GLP-1Ra leads to a slight reduction in bone mineral density and promotes bone remodeling, favoring resorption similar to calorie restriction effects, further research is needed to explore the effects of GLP-1Ra on bone metabolism and fracture-related outcomes, as well as dual- and triple-receptor agonists of GLP-1, glucose-dependent insulinotropic polypeptide (GIP), and glucagon in PwO
hrs.2025.107770 Chen SD, Chuang YC, Lin TK, Yang JL (2023) Alternative role of glucagon-like Peptide-1 receptor agonists in neurodegenerative diseases